Interpretation of genomic sequencing: variants should be considered uncertain until proven guilty
Author:
- 1 March 2018
- journal article
- editorial
- Published by Elsevier in Genetics in Medicine
- Vol. 20 (3) , 291-293
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- “Not pathogenic until proven otherwise”: perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes ProjectGenetics in Medicine, 2018
- Using high-resolution variant frequencies to empower clinical genome interpretationGenetics in Medicine, 2017
- Variant Interpretation: Functional Assays to the RescueThe American Journal of Human Genetics, 2017
- The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult PatientsAnnals of Internal Medicine, 2017
- Electronic health record phenotype in subjects with genetic variants associated with arrhythmogenic right ventricular cardiomyopathy: a study of 30,716 subjects with exome sequencingGenetics in Medicine, 2017
- Analysis of protein-coding genetic variation in 60,706 humansNature, 2016
- Your DNA is not your diagnosis: getting diagnoses right following secondary genomic findingsGenetics in Medicine, 2016
- Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical RecordsJAMA, 2016
- How do research participants perceive “uncertainty” in genome sequencing?Genetics in Medicine, 2014
- New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variantsEuropean Journal of Human Genetics, 2013